Join us

VINPOCETINE LAUNCHED IN BOSNIA

Share This Post

Share on facebook
Share on linkedin
Share on twitter

One of our partners in Bosnia (AMSAL) launched a new SKU Memoxa 5mg (Vinpocetine) successfully, after more than a year of fruitful sales and good marketing results with Memoxa 10mg.


This is the first ever Vinpocetine molecule drug launched in the Bosnian market.


Vinpocetine is used to enhance memory and increase brain metabolism. It has also been used for ischemia and reperfusion injury and is considered a neuroprotective agent.

 

This is a first ever Vinpocetine molecule launched on Bosnian market. Vinpocetine is used to enhance memory and increase brain metabolism. It has also been used for ischemia and reperfusion injury, and is considered a neuroprotective agent.